Personalized dementia prevention program for older adults
Kimel Family Centre for Brain Health and Wellness
This study is testing a personalized program to help older adults reduce their risk of dementia by focusing on areas like exercise, diet, mental health, and social connections.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 450 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | Baycrest Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT06933667 on ClinicalTrials.gov |
What this trial studies
This program involves 450 participants aged 50 and older who do not have a dementia diagnosis. They undergo a comprehensive dementia risk assessment that evaluates both nonmodifiable and modifiable risk factors. Based on this assessment, participants receive a Personalized Dementia Risk Report and Program Strategy, which highlights their risk levels in five key areas: physical activity, brain-healthy eating, cognitive engagement, social connections, and mental wellbeing. Participants then engage in targeted programs at the Centre to address these risk factors, with follow-up assessments every six months and comprehensive evaluations annually.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 50 and older who are fluent in English and do not have a dementia diagnosis.
Not a fit: Patients who have already been diagnosed with dementia will not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly reduce the risk of dementia in older adults through personalized lifestyle interventions.
How similar studies have performed: Other studies focusing on lifestyle interventions for dementia prevention have shown promising results, indicating that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 50 years or older * Sufficiently fluent in English to complete the assessments and participate in programming. Exclusion Criteria: * Diagnosis of dementia.
Where this trial is running
Toronto, Ontario
- Baycrest — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Nicole D. Anderson, PhD, CPsych — Baycrest
- Study coordinator: Nicole D. Anderson, PhD, CPsych
- Email: nanderson@research.baycrest.org
- Phone: 416-785-2500
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.